Skip to content

Clinical trials

Phase 1/2 Neoplasm Metastasis trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Phase 1/2 Country / region: China Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20151
20161
20184
20192
20205
20215
20222
20233
20242
20252
202610

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting18
Unknown status12
Active, not recruiting4
Completed3
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beijing Biotech6
Chinese PLA General Hospital5
Shanghai EpimAb Biotherapeutics Co., Ltd.3
Essen Biotech2
Novartis Pharmaceuticals2
Shenzhen Ionova Life Sciences Co., Ltd.2
AstraZeneca1
Avenzo Therapeutics, Inc.1
Capital Medical University1
Chinese Academy of Medical Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis38
Breast Neoplasms8
Neoplasms7
Carcinoma, Non-Small-Cell Lung6
Ovarian Neoplasms5
Pancreatic Neoplasms5
Biliary Tract Neoplasms4
Colorectal Neoplasms4
Liver Neoplasms4
Lymphoma4

Trials

Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.